Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex

被引:542
作者
Tan, Qiuxiang [1 ]
Zhu, Ya [1 ]
Li, Jian [1 ]
Chen, Zhuxi [2 ]
Han, Gye Won [3 ]
Kufareva, Irina [4 ]
Li, Tingting [1 ]
Ma, Limin [1 ]
Fenalti, Gustavo [3 ]
Li, Jing [1 ]
Zhang, Wenru [1 ]
Xie, Xin [1 ]
Yang, Huaiyu [2 ]
Jiang, Hualiang [2 ]
Cherezov, Vadim [3 ]
Liu, Hong [1 ]
Stevens, Raymond C. [1 ,3 ,5 ]
Zhao, Qiang [1 ]
Wu, Beili [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China
[3] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
[4] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[5] ShanghaiTech Univ, iHuman Inst, Shanghai 201203, Peoples R China
基金
美国国家科学基金会;
关键词
CRYSTAL-STRUCTURE; SMALL-MOLECULE; CORECEPTOR; BINDING; DISCOVERY; TERMINUS; ANTIBODY;
D O I
10.1126/science.1241475
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry. Here we report the 2.7 angstrom-resolution crystal structure of human CCR5 bound to the marketed HIV drug maraviroc. The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry. A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity. These high-resolution insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.
引用
收藏
页码:1387 / 1390
页数:4
相关论文
共 27 条
[1]   Chemokines and leukocyte traffic [J].
Baggiolini, M .
NATURE, 1998, 392 (6676) :565-568
[2]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[3]   Functional impact of HIV coreceptor-binding site mutations [J].
Biscone, Mark J. ;
Miamidian, John L. ;
Muchiri, John M. ;
Balk, Sarah S. W. ;
Lee, Fang-Hua ;
Doms, Robert W. ;
Reeves, Jacqueline D. .
VIROLOGY, 2006, 351 (01) :226-236
[4]  
Blanpain C, 1999, BLOOD, V94, P1899
[5]   The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle [J].
Blanpain, C ;
Doranz, BJ ;
Bondue, A ;
Govaerts, C ;
De Leener, A ;
Vassart, G ;
Doms, RW ;
Proudfoot, A ;
Parmentier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) :5179-5187
[6]   Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities [J].
Brelot, A ;
Heveker, N ;
Montes, M ;
Alizon, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23736-23744
[7]   Structural basis for coreceptor selectivity by the HIV type 1 V3 loop [J].
Cardozo, Timothy ;
Kimura, Tetsuya ;
Philpott, Sean ;
Weiser, Barbara ;
Burger, Harold ;
Zolla-Pazner, Susan .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (03) :415-426
[8]   Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist [J].
Chien, Ellen Y. T. ;
Liu, Wei ;
Zhao, Qiang ;
Katritch, Vsevolod ;
Han, Gye Won ;
Hanson, Michael A. ;
Shi, Lei ;
Newman, Amy Hauck ;
Javitch, Jonathan A. ;
Cherezov, Vadim ;
Stevens, Raymond C. .
SCIENCE, 2010, 330 (6007) :1091-1095
[9]   Assessing chemokine co-receptor usage in HIV [J].
Coakley, E ;
Petropoulos, CJ ;
Whitcomb, JM .
CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (01) :9-15
[10]   Recognition of RANTES by extracellular parts of the CCR5 receptor [J].
Duma, Luminita ;
Haeussinger, Daniel ;
Rogowski, Marco ;
Lusso, Paolo ;
Grzesiek, Stephan .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 365 (04) :1063-1075